Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Osteo Bi-Flex Claims Score Partial Victory In Appeal Of NAD Recommendation

This article was originally published in The Tan Sheet

Executive Summary

The National Advertising Division's review board upheld most points of a recommendation that Rexall Sundown stop making certain claims for Osteo Bi-Flex dietary supplements, but said some claims can be used in ads and on packaging if "they are clearly qualified.

You may also be interested in...

Neurocet Cliff's Notes Fail NAD Test For 'Stronger Than Morphine' Claim

NAD says direct advertising claims for the Neurocet supplement rely on insufficient or ill-fitted research – including summaries – and marketer National Media Group should discontinue numerous statements challenged by the Council for Responsible Nutrition.

In Brief

Osteo Bi-Flex clears NAD claims review

In Brief

Osteo Bi-Flex clears NAD claims review

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts